Oppenheimer lowered the firm’s price target on Agilysys (AGYS) to $90 from $135 on group multiples compression, while keeping an Outperform rating on the shares. The firm’s research mosaic points to better execution in the Q4 results, but downside risk in the initial FY26 revenue guidance.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGYS: